Evidence map›Paper›PMID 31552482›Full record

ArticleActa neuropathologica2020

The active contribution of OPCs to neuroinflammation is mediated by LRP1.

Anthony Fernández-Castañeda, Megan S Chappell, Dorian A Rosen, Scott M Seki, Rebecca M Beiter, David M Johanson, Delaney Liskey, Emily Farber, Suna Onengut-Gumuscu, Christopher C Overall and 2 more

Abstract read
In one paragraph

Article in Acta neuropathologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Long-Term Excessive Alcohol Consumption Enhances Myelination in the Mouse Nucleus Accumbens.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anthony Fernández-CastañedaDepartment of Neuroscience, Center for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA, 22908, USA.
Megan S ChappellDepartment of Neuroscience, Center for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA, 22908, USA.
Dorian A RosenDepartment of Neuroscience, Center for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA, 22908, USA.
Scott M SekiDepartment of Neuroscience, Center for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA, 22908, USA.
Rebecca M BeiterDepartment of Neuroscience, Center for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA, 22908, USA.
David M JohansonDepartment of Neuroscience, Center for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA, 22908, USA.
Delaney LiskeyDepartment of Neuroscience, Center for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA, 22908, USA.
Emily FarberCenter for Public Health Genomics, School of Medicine, University of Virginia, Charlottesville, VA, 22908, USA.
Suna Onengut-GumuscuCenter for Public Health Genomics, School of Medicine, University of Virginia, Charlottesville, VA, 22908, USA.
Christopher C OverallDepartment of Neuroscience, Center for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA, 22908, USA.
Jeffrey L DupreeDepartment of Anatomy and Neurobiology, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Alban GaultierDepartment of Neuroscience, Center for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA, 22908, USA. ag7h@virginia.edu.ORCID http://orcid.org/0000-0002-4175-6053

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
TRAINING IN THE PHARMACOLOGICAL SCIENCEST32GM007055 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LYNCH, KEVIN R. · 1985 to 2022
$7.2M
PREDOCTORAL TRAINING IN NEUROSCIENCET32GM008328 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LEE, KEVIN SCOTT · 1992 to 2017
$3.9M
Role of LRP1 in NF-kB mediated neuroinflammationR01NS083542 · NINDS · UNIVERSITY OF VIRGINIA · PI GAULTIER, ALBAN P · 2015 to 2019
$1.9M
Diversity of oligodendrocyte precursor cells in the adult central nervous systemR21NS111204 · NINDS · UNIVERSITY OF VIRGINIA · PI GAULTIER, ALBAN P · 2019 to 2019
$435k
Targeting metabolic vulnerabilities of immune cells to treat CNS demyelinationF31NS103327 · NINDS · UNIVERSITY OF VIRGINIA · PI SEKI, SCOTT M · 2017 to 2017
$29k
National Multiple Sclerosis Society PP1978NIGMS NIH HHS T32 GM007055NIGMS NIH HHS T32 GM007267NIGMS NIH HHS T32 GM008328NINDS NIH HHS F31 NS103327NINDS NIH HHS R01 NS083542NINDS NIH HHS R21 NS111204
6 · The paper itself

Abstract

Oligodendrocyte progenitor cells (OPCs) account for about 5% of total brain and spinal cord cells, giving rise to myelinating oligodendrocytes that provide electrical insulation to neurons of the CNS. OPCs have also recently been shown to regulate inflammatory responses and glial scar formation, suggesting functions that extend beyond myelination. Low-density lipoprotein receptor-related protein 1 (LRP1) is a multifaceted phagocytic receptor that is highly expressed in several CNS cell types, including OPCs. Here, we have generated an oligodendroglia-specific knockout of LRP1, which presents with normal myelin development, but is associated with better outcomes in two animal models of demyelination (EAE and cuprizone). At a mechanistic level, LRP1 did not directly affect OPC differentiation into mature oligodendrocytes. Instead, animals lacking LRP1 in OPCs in the demyelinating CNS were characterized by a robust dampening of inflammation. In particular, LRP1-deficient OPCs presented with impaired antigen cross-presentation machinery, suggesting a failure to propagate the inflammatory response and thus promoting faster myelin repair and neuroprotection. Our study places OPCs as major regulators of neuroinflammation in an LRP1-dependent fashion.

Indexed as

AnimalsCell Culture TechniquesCell DifferentiationCuprizoneEncephalomyelitis, Autoimmune, ExperimentalHistocompatibility Antigens Class IHumansLow Density Lipoprotein Receptor-Related Protein-1MiceMice, Inbred C57BLMultiple SclerosisOligodendrocyte Precursor CellsCuprizoneHistocompatibility Antigens Class ILow Density Lipoprotein Receptor-Related Protein-1LRP1 protein, humanLrp1 protein, mouseAntigen cross-presentationDemyelinationLRP1MHC1Multiple sclerosisOligodendrocyte progenitor cells

Identifiers

PMID31552482
PMCPMC6994364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.